PredictCan Presents Its DILI Platform at the 3RsC & IQ Consortium Liver MPS Webinar
PredictCan CTO Dr. Sara Cherradi presented the company’s individual-centric DILI platform during the “Revisiting Liver MPS” webinar organized as part of the 3Rs Collaborative and IQ Consortium Webinar Series.
PredictCan and PreClinBio Solutions Launch Strategic India–Europe Collaboration
PredictCan Biotechnologies and PreClinBio Solutions LLP have established a strategic collaboration connecting complementary expertise in preclinical research and human-relevant biotechnology to support translational drug development and strengthen scientific ties between India and Europe.
PredictCan Joins FDA ISTAND Initiative to Advance Liver MPS for Drug Safety
PredictCan Biotechnologies is participating in a 3Rs Collaborative initiative accepted into the FDA ISTAND program, bringing together regulators, technology providers, and industry end-users to evaluate liver microphysiological systems for drug-induced liver injury assessment.